Patent · US Active

Quinoline derivatives 057

US8106073B2 · kind B2 · utility

0Cited by

9References

7Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Simon Guile · Coalville, GB
Toby Thompson · Loughborough, GB

Key dates

Filing date	Nov 26, 2008
Grant date	Jan 31, 2012
Priority date	—
Expiry date	Apr 18, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a compound of formula (I) as defined in the specification, a process for its preparation, pharmaceutical compositions containing it, a process for preparing the pharmaceutical composition, and its use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.